NovaBay Pharmaceuticals, Inc. (AMEX:NBY) Q3 2023 Earnings Call Transcript

Page 2 of 2

Justin Hall: Yes. Absolutely. We love this. We look at it all the time, and we track it fairly closely because the Avenova Spray is our highest volume and most popular product across the entire company. And it’s a consumable. So and dry eye is a chronic problem. So once somebody uses it and they like it and it works for them, they will just keep on buying it the same way that they buy other sort of self-care products. So we like to make the analogy with toothpaste, right? Once people say like, I need to brush my teeth with toothpaste, right? They just keep on buying toothpaste. And so the long-term value of an Avenova customer is a focus of ours because we really want to reach out and touch those customers that buy the product once, maybe it’s recommended by their doctor, they buy at once.

But they need to be reminded to buy it again and buy it on a regular basis. So about 20% of our Amazon sales come from subscribe and save, and those are people who have signed up to receive at least one product each month, automatically.

Destiny Buch: Okay. Got it. You answered my next question. That was very helpful. Thank you. And then lastly, because I’m definitely hogging the line here.

Justin Hall: That’s okay.

Destiny Buch: You know how I am, Justin. By 10 collaborations, I’m wondering if you can just touch a little bit more on the commercial strategy, so I can better understand that. And then have you gotten any initial feedback? Have you had any physicians use it yet? And then what exactly is the money flow for this partnership?

Justin Hall: Yes. So this is a prescription-only product that we obviously, as I mentioned, sell through the physician-dispensed channel. So we originally started just reaching out to all of the doctors that we have really good relationships with, through Avenova saying, oh, we have a new product. The product price is $300 per allograft. So it’s $300 for one tissue. And the doctor, most often times can apply for insurance coverage, either private insurance coverage or Medicare reimbursement. But the Medicare reimbursement is done for the procedure. So the doctor has to buy the tissue from us for cash and then do the procedure with the patient and then apply separately for Medicare reimbursement for the entire procedure. And depending on the coverage and the procedure and the patient, Medicare coverage can range from $1,000 to $1,300.

Destiny Buch: Okay. Excellent. I think that does it for me. Thank you so much for taking the questions.

Justin Hall: Sure. Yes, of course. As always. Thank you.

Operator: The next question will come from [Rafe Khalid] with Ascendiant Capital Markets. Please go ahead. It seems that Mr. Khalid has left the question queue. I will turn the call back over to Mr. Justin Hall for any closing remarks.

Justin Hall: Thank you for joining us. We’re excited about our progress and the promising future that we envision for our company. We’ll be holding meetings with investment professionals during the 2024 JPMorgan Healthcare Conference being held at January 8 through 11 in San Francisco. If you’re interested in setting up a meeting with us, please contact LHA Investor Relations. Thanks again, and have a nice day.

Operator: The conference has now concluded. Thank you for attending today’s presentation. You may now disconnect.

Follow Novabay Pharmaceuticals Inc. (NYSEMKT:NBY)

Page 2 of 2